JPS6210988B2 - - Google Patents

Info

Publication number
JPS6210988B2
JPS6210988B2 JP52119387A JP11938777A JPS6210988B2 JP S6210988 B2 JPS6210988 B2 JP S6210988B2 JP 52119387 A JP52119387 A JP 52119387A JP 11938777 A JP11938777 A JP 11938777A JP S6210988 B2 JPS6210988 B2 JP S6210988B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
general formula
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP52119387A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5368775A (en
Inventor
Kotsupe Heruberuto
Mentorutsupu Anton
Otsuto Rente Erunsuto
Shoromu Kuruto
Hohefuke Uorufugangu
Muasebitsuku Goyuko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
C.H. Boehringer Sohn AG and Co KG
Original Assignee
C.H. Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C.H. Boehringer Sohn AG and Co KG filed Critical C.H. Boehringer Sohn AG and Co KG
Publication of JPS5368775A publication Critical patent/JPS5368775A/ja
Publication of JPS6210988B2 publication Critical patent/JPS6210988B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Quinoline Compounds (AREA)
JP11938777A 1976-10-05 1977-10-04 11aryloxyy22mydroxyy33 alkyleneaminopropane Granted JPS5368775A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762644833 DE2644833A1 (de) 1976-10-05 1976-10-05 Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
JPS5368775A JPS5368775A (en) 1978-06-19
JPS6210988B2 true JPS6210988B2 (enExample) 1987-03-10

Family

ID=5989679

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11938777A Granted JPS5368775A (en) 1976-10-05 1977-10-04 11aryloxyy22mydroxyy33 alkyleneaminopropane

Country Status (33)

Country Link
US (7) US4256756A (enExample)
JP (1) JPS5368775A (enExample)
AT (15) AT361908B (enExample)
AU (1) AU514600B2 (enExample)
BE (1) BE859415A (enExample)
BG (1) BG33153A3 (enExample)
CA (4) CA1101859A (enExample)
CS (1) CS197304B2 (enExample)
DD (5) DD148052A5 (enExample)
DE (1) DE2644833A1 (enExample)
DK (1) DK439077A (enExample)
ES (16) ES462868A1 (enExample)
FI (1) FI69066C (enExample)
FR (1) FR2394534A1 (enExample)
GB (3) GB1592975A (enExample)
GR (1) GR64229B (enExample)
HK (1) HK19385A (enExample)
HU (1) HU177173B (enExample)
IE (3) IE46159B1 (enExample)
IL (1) IL53043A (enExample)
LU (1) LU78240A1 (enExample)
MY (1) MY8500909A (enExample)
NL (1) NL7710840A (enExample)
NO (1) NO151411C (enExample)
NZ (1) NZ185356A (enExample)
PH (4) PH15763A (enExample)
PL (1) PL113879B1 (enExample)
PT (1) PT67107B (enExample)
SE (1) SE442400B (enExample)
SG (1) SG70884G (enExample)
SU (1) SU665801A3 (enExample)
YU (1) YU40484B (enExample)
ZA (1) ZA775905B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4404380A (en) * 1977-02-14 1983-09-13 Mead Johnson & Company Triazolopyrimidines
DE2833140A1 (de) * 1978-07-28 1980-02-07 Boehringer Sohn Ingelheim Neue n-substituierte heterocyclen
FR2455587A1 (fr) * 1979-05-04 1980-11-28 Continental Pharma Derives de benzimidazole, leur preparation et utilisation dans le traitement des affections cardiovasculaires et compositions les contenant
US4434174A (en) 1980-02-11 1984-02-28 Berlex Laboratories, Inc. Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
IE810250L (en) 1980-02-11 1981-08-11 Berlex Lab N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4349673A (en) * 1980-12-23 1982-09-14 Merck & Co., Inc. Benzoxazines
US4656168A (en) * 1980-12-23 1987-04-07 Merck & Co., Inc. (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation
US4473501A (en) * 1981-05-04 1984-09-25 G. D. Searle & Co. Dihydro azino isoquinolines
US4379508A (en) * 1981-10-14 1983-04-12 Nestier Corporation Nesting tray with stacking keyed interlock
IT1193608B (it) * 1983-01-21 1988-07-21 Pierrel Spa Derivati di arilossipropanolamina,procedimento per la loro preparazione composizioni farmaceutiche che li contengono e loro impiego terapeutico
DE3324903A1 (de) * 1983-07-09 1985-01-17 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung substituierter ethylenharnstoffe sowie neue n-vinylethylenharnstoffe
GB8419797D0 (en) * 1984-08-03 1984-09-05 Beecham Group Plc Compounds
DE3807922A1 (de) * 1988-03-10 1989-09-21 Boehringer Mannheim Gmbh Substituierte heterocyclen, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
TW203049B (enExample) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
US6860524B1 (en) 1993-05-14 2005-03-01 William W. Rowley Polyolefin connectors
US6557907B2 (en) 1993-05-14 2003-05-06 William W. Rowley Polyethylene connectors
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
CA2450073C (en) 2001-07-25 2017-08-29 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6848719B2 (en) 2001-09-06 2005-02-01 William W. Rowley Bendable polymer-lined water heater connector
MY143244A (en) * 2002-11-26 2011-04-15 Smithkline Beecham Corp Calcilytic compounds
AU2003300297A1 (en) * 2002-12-23 2004-07-22 Artesian Therapeutics, Inc. CARDIOTONIC COMPOUNDS WITH INHIBITORY ACTIVITY AGAINST Beta-ADRENERGIC RECEPTORS AND PHOSPHODIESTERASE
DE102004045648A1 (de) * 2004-09-21 2006-03-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika zur Behandlung von Atemwegserkrankungen
JP2008521805A (ja) * 2004-11-30 2008-06-26 アーテシアン セラピューティクス， インコーポレイテッド β−アドレナリン作用性受容体およびホスホジエステラーゼに対する阻害活性を有する強心性化合物
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質（ｒａｐ）結合体の投与による肝障害の処置
ES2582555T3 (es) * 2007-11-29 2016-09-13 Inolex Investment Corporation Conservantes para composiciones cosméticas, de tocador y farmacéuticas
ES2919563T3 (es) 2009-02-20 2022-07-27 Enhanx Biopharm Inc Sistema de administración de medicamentos a base de glutatión
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL284529A (enExample) * 1961-10-24
GB1066613A (en) * 1965-03-03 1967-04-26 Ici Ltd Naphthalene derivatives
FR2073434B1 (enExample) * 1969-11-28 1975-08-01 Teikoku Hormone Mfg Co Ltd
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US3894030A (en) * 1973-01-04 1975-07-08 Janssen Pharmaceutica Nv 1-{8 1-(2-Hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
US3818017A (en) * 1973-01-04 1974-06-18 Janssen Pharmaceutica Nv 1-{8 1-(2-hydroxy-3-aryloxypropyl)-4-piperidyl{9 -2-benzimidazolinones and related compounds
GB1456525A (en) * 1973-07-18 1976-11-24 Ici Ltd Process for the manufacture of alkanolamine derivatives
DE2503222A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Verfahren zur herstellung von 1-aryl- oxy-3-n-substituierten aminopropanderivaten
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (enExample) * 1976-01-08 1981-07-31 Ciba Geigy Ag
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen

Also Published As

Publication number Publication date
CA1127643A (en) 1982-07-13
US4343800A (en) 1982-08-10
ES471795A1 (es) 1979-02-01
ATA57680A (de) 1980-12-15
AT362363B (de) 1981-05-11
AT361912B (de) 1981-04-10
JPS5368775A (en) 1978-06-19
AT362364B (de) 1981-05-11
ATA57280A (de) 1980-10-15
IE46159B1 (en) 1983-03-09
DK439077A (da) 1978-04-06
MY8500909A (en) 1985-12-31
HK19385A (en) 1985-03-22
US4296117A (en) 1981-10-20
US4256756A (en) 1981-03-17
ES471807A1 (es) 1979-02-01
US4255430A (en) 1981-03-10
FR2394534B1 (enExample) 1982-04-30
AU2933377A (en) 1979-04-12
PH19028A (en) 1985-12-06
FI69066B (fi) 1985-08-30
ES471804A1 (es) 1979-02-01
ATA57580A (de) 1980-12-15
FI69066C (fi) 1985-12-10
ATA57480A (de) 1980-10-15
PH15763A (en) 1983-03-22
US4604468A (en) 1986-08-05
ES471805A1 (es) 1979-02-01
ES471802A1 (es) 1979-02-01
SE7711168L (sv) 1978-05-18
ATA57080A (de) 1980-09-15
NZ185356A (en) 1981-05-01
AT363082B (de) 1981-07-10
BG33153A3 (bg) 1982-12-15
ES462868A1 (es) 1978-12-16
PL113879B1 (en) 1981-01-31
DE2644833A1 (de) 1978-04-20
ES471800A1 (es) 1979-02-01
ES471796A1 (es) 1979-02-01
DD148051A5 (de) 1981-05-06
PT67107B (de) 1980-04-07
GB1592977A (en) 1981-07-15
AT363079B (de) 1981-07-10
CA1126271A (en) 1982-06-22
AT364828B (de) 1981-11-25
SE442400B (sv) 1985-12-23
AT361914B (de) 1981-04-10
ATA57780A (de) 1980-12-15
AT363080B (de) 1981-07-10
IE822409L (en) 1978-04-05
AT362362B (de) 1981-05-11
GR64229B (en) 1980-02-14
LU78240A1 (enExample) 1979-02-02
SG70884G (en) 1985-04-04
ATA56980A (de) 1980-09-15
US4381309A (en) 1983-04-26
IE46160B1 (en) 1983-03-09
NL7710840A (nl) 1978-04-07
DD143074A5 (de) 1980-07-30
NO151411B (no) 1984-12-27
CS197304B2 (en) 1980-04-30
NO151411C (no) 1985-04-10
GB1592976A (en) 1981-07-15
AT361911B (de) 1981-04-10
US4212877A (en) 1980-07-15
ES471801A1 (es) 1979-02-01
FR2394534A1 (fr) 1979-01-12
AT361913B (de) 1981-04-10
ATA57380A (de) 1980-10-15
ES471803A1 (es) 1979-02-01
ATA57980A (de) 1980-12-15
DD148050A5 (de) 1981-05-06
ATA56780A (de) 1980-09-15
IL53043A0 (en) 1977-12-30
ZA775905B (en) 1979-06-27
ATA679377A (de) 1980-09-15
ES471798A1 (es) 1979-02-01
AT362365B (de) 1981-05-11
ES471797A1 (es) 1979-02-01
CA1101859A (en) 1981-05-26
ES471806A1 (es) 1979-02-01
YU236977A (en) 1983-01-21
FI772823A7 (fi) 1978-04-06
BE859415A (fr) 1978-04-05
AT361915B (de) 1981-04-10
IL53043A (en) 1982-01-31
DD134642A5 (de) 1979-03-14
ATA57880A (de) 1980-10-15
ES471799A1 (es) 1979-02-01
ES471808A1 (es) 1979-02-01
PT67107A (de) 1977-11-01
DD148052A5 (de) 1981-05-06
YU40484B (en) 1986-02-28
NO773384L (no) 1978-04-06
ATA58080A (de) 1981-04-15
PH16053A (en) 1983-06-09
IE46158B1 (en) 1983-03-09
PL201286A1 (pl) 1978-12-04
IE822410L (en) 1978-04-05
PH18363A (en) 1985-06-13
CA1125751A (en) 1982-06-15
AT363081B (de) 1981-07-10
ATA56880A (de) 1980-09-15
SU665801A3 (ru) 1979-05-30
AU514600B2 (en) 1981-02-19
GB1592975A (en) 1981-07-15
HU177173B (en) 1981-08-28
ATA57180A (de) 1980-09-15
IE46158L (en) 1978-04-05
ES471794A1 (es) 1979-02-01
AT361908B (de) 1981-04-10

Similar Documents

Publication Publication Date Title
CA1125751A (en) Substituted cyclic amines
CA1086317A (en) Aminoalkyl heterocycles
FI79841B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla aminotetralinderivat.
US4234595A (en) 3-Indolyl-tertiary butylaminopropanols
US4988690A (en) 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
JPS5912113B2 (ja) エタノ−ルアミン誘導体又はその酸付加塩の製法
JPH0261465B2 (enExample)
JP2008266333A (ja) Ｌｔｂ４−アンタゴニスト活性を有するベンズアミジン誘導体及びその医薬としての使用
JPS6215546B2 (enExample)
US3644469A (en) 1-(cyanophenoxy)-2-hydroxy-3-sec.-alkylamino-propanes
CS236679B2 (en) Manufacturing process of new benzoheterocyclic compounds
US4391821A (en) 7-Substituted benzopyranes and process for the preparation thereof
JPS594417B2 (ja) シンキノ １− アリ−ルオキシ −２− ヒドロキシ −３− アルキニルアミノプロパンノ セイゾウホウホウ
CA1061357A (en) Phenylalkylamines
HU183515B (en) Process for preparing 3,1-benzoxazin-2-one derivatives
EP0558487A1 (en) Piperidine compounds, their preparation and use
EP0034116A2 (en) N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
JPS6227062B2 (enExample)
JPS60255776A (ja) ジヒドロピリダジノン誘導体
IE49549B1 (en) Piperazine derivatives
JPS6214545B2 (enExample)
US3997608A (en) N-substituted-dihydroxyphenethylamines
JPS6149314B2 (enExample)
JPH034073B2 (enExample)
KR820000384B1 (ko) 1-아릴옥시-2-하이드록시-3-알킬렌아미노프로판의 제조방법